Launa Aspeslet is an accomplished life science executive and board member with over 20 years of leadership experience in scaling early-stage organizations to sustainable growth and maturity. She excels in multi-stakeholder environments, new product development, and guiding entrepreneurs through organizational transformation.
Currently, Launa also serves as Senior Clinical & Regulatory Advisor to Model Medicines and a Board member of Edmonton Unlimited. She recently acted as interim CEO at Edmonton Unlimited and has held roles as COO at Hepion Pharmaceuticals, CEO of TRIO, and COO at Isotechnika Pharma. She has also provided strategic consulting for various early-stage drug and medical device companies. During this time, Launa has led teams to conduct over 50 clinical trials, enrolling more than 10,000 patients across 20 countries.
She holds a BSc in chemistry from the University of Lethbridge and a PhD in Pharmaceutical Sciences from the University of Alberta, along with a Regulatory Affairs Certification (RAC).